News

18
Jan

ACYTE Biotech and Xell AG announce strategic partnership and launch AXYTE product and services portfolio

ACYTE and Xell launch AXYTE cells + media products

Read More
15
Feb

MEDVET SCIENCE LICENSES XL-99 CELL LINE FOR ONCOLOGY ANTIBODY

Medvet Science has licenced Acyte's XL-99 CHO stable cell line.

Read More
12
Jun

ACYTE Attending ISSCR and BIO

Acyte will be attending the International Society for Stem Cell Research

Read More
17
Jan

ACYTE PRESENTS AT PEP TALK 2014

Professor Peter Gray, Director of the Australian Institute for Bioengineering and...

Read More
4
Nov

ACYTE PRESENTS AT THE SECOND ANTIBODY THERAPEUTIC CONFERENCE: DESIGN, CHARACTERIZATION AND TRANSLATION IN TAIWAN

Professor Peter Gray, Director of the Australian Institute for Bioengineering and...

Read More
26
Sep

ACYTE PRESENTS AT THE 2nd ANNUAL CELL CULTURE ENGINEERING WORLD CONFERENCE IN SINGAPORE

Professor Stephen Mahler, Head of Discipline Chemical and Biological Engineering, Australian Institute...

Read More
8
Sep

ACYTE PRESENTS AT INTERNATIONAL CONFERENCE ON BIONANO INNOVATION 2013 IN CHINA

Dr Jeff Hou, Senior Research Officer at the Australian Institute for Bioengineering and...

Read More

News